Le Lézard
Classified in: Health, Science and technology
Subjects: Contract/Agreement, Product/Service

Seven and Eight Biopharmaceuticals Inc. Announces Clinical Collaboration

Seven and Eight Biopharmaceuticals Inc. today announced that it has signed a clinical research collaboration agreement with Roche to explore the combination of Seven and Eight's BDB001, an immune modulator targeting toll-like receptors (TLR) 7 and 8, and atezolizumab, a monoclonal antibody against the checkpoint target of PD-L1, in treating solid tumors.

"We are pleased to enter into clinical collaboration with Roche," says Dr. Walter Lau, CEO of Seven and Eight. "Toll-like receptors 7 and 8 are amongst the most promising targets for immuno-oncology, and our dual agonists have demonstrated the ability to stimulate specific types of innate immune responses, generating enhanced adaptive anti-tumor immunity. We hope through our joint efforts with Roche, we can better delineate how to use BDB001 and atezolizumab together in the treatment of cancer patients."

Under the terms of the agreement, Seven and Eight will sponsor and be responsible for the conduct of the clinical study, in which the combined regimen of BDB001 and atezolizumab is studied for safety and tolerability, pharmacokinetics, pharmacodynamics, and anti-tumor activities in solid tumor patients.

About Seven and Eight Biopharmaceuticals Inc.

Seven and Eight Biopharmaceuticals Inc. is an Edison, NJ-based, clinical-stage biotech company focused on the development and commercialization of novel immunotherapies for cancer. The company specializes in TLR7/8 programs to treat cancer and has built a comprehensive global intellectual property portfolio in the category of toll-like receptor modulators. Managed by a seasoned team of professionals, the company is progressing a proprietary pipeline of cancer therapeutics, with the lead product BDB001 in Phase I clinical trials in the U.S.

These press releases may also interest you

at 11:55
Remittance solutions, like all financial products, are continuously subject to innovation and technology advancements that improve the experience of their users. While many efforts have focused on improving the money sending process, few have done so...

at 11:50
FutureFuel.io, a technology provider of student debt employer benefits solutions, today announced the launch of a new program with First Data, a global leader in commerce-enabling technology and solutions. The program offers qualified First Data...

at 11:47
Casio is known as a trailblazer in many business units within the electronics industry with several first-to-market products including the first consumer digital camera with built-in LCD, first graphing calculator and first digital watch. As it...

at 11:45
Citing recent reports of British Airways facing record $229 million penalties in the UK for violating data protection and privacy rules under the European General Data Protection Regulation (GDPR), John Shegerian, Co-Founder and Executive Chairman of...

at 11:45
CloudBerry Lab, the #1 MSP backup, today announced a full rebrand to MSP360. This new identity better communicates the company's vision of becoming the premier platform for MSPs. As the #1 backup solution for managed service providers, MSP360...

at 11:39
Azavar Government Solutions has tapped a long-time veteran of municipal audits, Ted Kamel to be the company's new senior Vice President. Kamel, a Texas native, will primarily work on developing sales for Azavar's Local Gov software, which makes it...

News published on 19 june 2019 at 20:05 and distributed by: